Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 9.23%1.37B | 18.54%922.6M | 5.57%483.06M | -13.09%2.06B | -14.31%1.26B | -21.47%778.32M | -9.88%457.57M | -3.60%2.37B | -6.81%1.47B | -7.06%991.11M |
| Refunds of taxes and levies | -30.84%11.54M | -12.18%11.35M | 29.62%9.4M | -52.86%16.36M | -35.05%16.69M | -35.48%12.92M | -3.89%7.25M | -36.96%34.7M | -31.82%25.7M | -26.86%20.03M |
| Cash received relating to other operating activities | -40.37%73.44M | -35.72%46.86M | -36.63%25.94M | 40.90%245.66M | -19.00%123.16M | -37.65%72.9M | -14.05%40.94M | -9.98%174.35M | 12.49%152.04M | 14.80%116.91M |
| Cash inflows from operating activities | 4.37%1.46B | 13.50%980.82M | 2.50%518.4M | -9.98%2.33B | -15.07%1.4B | -23.40%864.14M | -10.15%505.76M | -4.74%2.58B | -5.86%1.64B | -5.65%1.13B |
| Goods services cash paid | 5.17%797.02M | 10.97%537.43M | 16.25%304.95M | -29.27%992.88M | -20.78%757.85M | -24.46%484.32M | -16.02%262.33M | 27.49%1.4B | 49.05%956.61M | 53.64%641.12M |
| Staff behalf paid | -9.39%401.25M | -7.99%299.86M | -26.26%138.15M | -1.13%548M | 0.89%442.84M | 3.21%325.89M | -4.95%187.35M | 2.50%554.26M | 6.48%438.92M | 6.34%315.75M |
| All taxes paid | 5.39%105.58M | -9.81%77.9M | -15.43%58.07M | -26.45%133.87M | -10.92%100.18M | -6.31%86.38M | 33.97%68.67M | 49.49%182M | 31.45%112.47M | 47.45%92.2M |
| Cash paid relating to other operating activities | -11.29%193.48M | -13.16%130.03M | -43.04%70.69M | -30.65%285.74M | -31.78%218.1M | -34.74%149.75M | 16.52%124.09M | 9.96%412.05M | 20.79%319.71M | 27.47%229.48M |
| Cash outflows from operating activities | -1.42%1.5B | -0.11%1.05B | -10.99%571.86M | -23.18%1.96B | -16.89%1.52B | -18.16%1.05B | -3.72%642.43M | 19.35%2.55B | 30.15%1.83B | 33.64%1.28B |
| Net cash flows from operating activities | 67.23%-40.29M | 64.65%-64.41M | 60.89%-53.45M | 1,074.84%365.01M | 33.19%-122.96M | -21.07%-182.19M | -31.00%-136.67M | -94.58%31.07M | -153.87%-184.05M | -163.00%-150.49M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -66.43%1.11M | -58.81%1.11M | -74.91%636.35K | -99.17%4.56M | -99.27%3.3M | 18.49%2.69M | 34.01%2.54M | -26.35%548.98M | -38.03%453.98M | -99.68%2.27M |
| Cash received from returns on investments | --4.42M | --2.96M | ---- | 1.40%65.91M | ---- | --0 | ---- | -0.82%65M | -97.98%1.58M | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -68.04%9.47M | -93.22%1.96M | -93.46%1.88M | 162,171.34%29.58M | 238,914.54%29.63M | 233,888.62%28.93M | 1,209,275.01%28.78M | -99.97%18.23K | -99.92%12.4K | -99.92%12.37K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --559.82K | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash received relating to other investing activities | --55K | ---- | --55K | --55K | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash inflows from investing activities | -54.27%15.06M | -80.94%6.03M | -91.78%2.58M | -83.60%100.67M | -92.77%32.93M | 1,284.80%31.62M | 1,552.65%31.32M | -29.05%614M | -44.85%455.57M | -99.70%2.28M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -62.86%10.1M | -58.08%5.74M | -53.74%4.16M | -78.19%35.1M | -69.19%27.18M | -76.20%13.69M | -63.22%9M | -16.92%160.9M | -46.15%88.23M | -45.71%57.51M |
| Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | --0 | ---- | -38.60%450M | -35.71%450M | -92.86%50M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Impawned loan net increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 | ---- |
| Cash outflows from investing activities | -62.86%10.1M | -58.08%5.74M | -53.74%4.16M | -94.26%35.1M | -94.95%27.18M | -87.27%13.69M | -87.91%9M | -35.47%610.9M | -37.69%538.23M | -86.66%107.51M |
| Net cash flows from investing activities | -13.62%4.96M | -98.38%290.5K | -107.12%-1.59M | 2,020.97%65.57M | 106.95%5.74M | 117.05%17.94M | 130.75%22.32M | 103.81%3.09M | -118.38%-82.66M | -87.38%-105.23M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from borrowing | -24.59%2.29B | 4.02%2.2B | 30.90%1.68B | 16.91%4.42B | 2.38%3.04B | -16.14%2.12B | -15.48%1.29B | 29.79%3.78B | 38.96%2.97B | 77.48%2.52B |
| Cash received relating to other financing activities | -53.37%257.05M | -41.19%250.95M | -53.47%130.95M | 46.93%539.92M | 4,920.78%551.28M | 3,786.43%426.73M | 54.67%281.44M | 76.67%367.47M | --10.98M | --10.98M |
| Cash inflows from financing activities | -29.00%2.55B | -3.57%2.45B | 15.75%1.81B | 19.56%4.96B | 20.50%3.59B | 0.32%2.54B | -7.98%1.57B | 32.91%4.15B | 39.47%2.98B | 78.25%2.54B |
| Borrowing repayment | -8.25%2.71B | 21.50%2.56B | 8.07%1.48B | 17.02%4.83B | 4.78%2.96B | 12.93%2.1B | 2.88%1.37B | 5.82%4.13B | 13.11%2.82B | -3.16%1.86B |
| Dividend interest payment | -7.56%89.27M | -3.85%63.83M | -1.62%35.11M | -21.31%127.06M | -16.69%96.57M | -2.47%66.39M | -18.44%35.69M | 2.93%161.47M | 8.95%115.91M | 17.40%68.07M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | --4.7K | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash payments relating to other financing activities | -89.75%34.42M | -87.52%28.77M | 8.78%13.47M | 132.09%108.99M | 1,183.31%335.73M | 832.45%230.42M | 51.49%12.38M | 28.44%46.96M | -0.62%26.16M | 332.65%24.71M |
| Cash outflows from financing activities | -16.31%2.84B | 10.33%2.65B | 7.83%1.53B | 16.84%5.07B | 14.35%3.39B | 22.75%2.4B | 2.50%1.42B | 5.91%4.34B | 12.80%2.96B | -1.59%1.96B |
| Net cash flows from financing activities | -240.34%-285.7M | -237.18%-195.95M | 89.73%287.48M | 43.52%-105.81M | 1,053.79%203.58M | -75.35%142.84M | -52.94%151.52M | 80.75%-187.34M | 103.60%17.64M | 202.56%579.53M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -93.00%116.04K | -93.38%150.27K | -91.39%158.18K | 229.18%1.68M | 262.38%1.66M | 474.78%2.27M | 487.35%1.84M | -414.56%-1.3M | -393.20%-1.02M | -788.89%-606.09K |
| Net increase in cash and cash equivalents | -464.58%-320.92M | -1,257.99%-259.92M | 496.24%232.6M | 311.33%326.46M | 135.20%88.02M | -105.92%-19.14M | -73.03%39.01M | 67.90%-154.48M | -34.87%-250.09M | 184.55%323.21M |
| Add:Begin period cash and cash equivalents | 93.94%673.8M | 93.94%673.8M | 93.84%673.45M | -30.78%347.34M | -30.77%347.43M | -30.77%347.43M | -30.77%347.43M | -48.95%501.82M | -48.95%501.82M | -48.95%501.82M |
| End period cash equivalent | -18.96%352.88M | 26.07%413.88M | 134.46%906.05M | 93.99%673.8M | 72.99%435.45M | -60.21%328.29M | -40.22%386.44M | -30.78%347.34M | -68.44%251.73M | 37.34%825.03M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.